Boston Children’s Hospital Takes Stake in For-Profit Genomics Company

Boston Children’s Hospital and biotechnology firm Life Technologies have launched Claritas Genomics, a for-profit joint venture that will look to develop new genomics-based healthcare solutions.

Advertisement

Boston Children’s, a non-profit, 395-bed teaching affiliate of Harvard Medical School, will be the majority owner. In a statement, hospital President and CEO Sandra Fenwick said the new company also aims to “advance the standard of care” through genomic sequencing and molecular diagnostics and extend the experiment to others around the country and world.

Investor-owned Life Technologies recorded sales of $3.7 billion in 2011.

More Articles on Non-Profit Hospital Finances:

5 Areas Where Hospitals Can Spend Smarter
4 Drivers of Healthcare Capital Financing — And How They Affect CFOs
UMass Memorial Medical Center Sells Lab Businesses

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Financial Management

  • Baylor College of Medicine and Texas Children’s Hospital established an affiliation more than 70 years ago in the Texas Medical…

  • Fitch revised Ontario, Calif.-based Prime Healthcare Services’ outlook to positive and affirms its “B” rating.  The revised outlook reflects Fitch’s…

  • Brentwood, Tenn.-based Lifepoint Health, a health system owned by private equity firm Apollo Global Management, has largely grown over the…

Advertisement

Comments are closed.